Yuanqing Wu

The transcription factor GATA‐6 is overexpressed in vivo and contributes to silencing 15‐LOX‐1 in vitro in human colon cancer

Jeffrey S. Morris, S. Lippman, R. Broaddus, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

Jeffrey S. Morris, I. Shureiqi, B. Fang, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.

Jeffrey S. Morris, R. Broaddus, I. Shureiqi, 2014, Journal of the National Cancer Institute.

Mechanistic Contribution of Ubiquitous 15-Lipoxygenase-1 Expression Loss in Cancer Cells to Terminal Cell Differentiation Evasion

Jeffrey S. Morris, J. Minna, R. Lotan, 2011, Cancer Prevention Research.

The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.

Jeffrey S. Morris, S. Lippman, B. Levin, 2005, Cancer research.

Role of STAT3 in the pathogenesis of nasopharyngeal carcinoma and its significance in anticancer therapy

Yi-Fan Si, Yuanqing Wu, Jinjing Xu, 2022, Frontiers in Oncology.

Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice.

Jeffrey S. Morris, Yan Wang, R. Broaddus, 2012, Journal of the National Cancer Institute.

The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells

Jeffrey S. Morris, Wei Jiang, S. Lippman, 2003, Proceedings of the National Academy of Sciences of the United States of America.

The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells

S. Lippman, Xiaopei Xi, L. Hsi, 2005, Molecular Cancer Therapeutics.

15-LOX-1 suppression of hypoxia-induced metastatic phenotype and HIF-1α expression in human colon cancer cells

I. Shureiqi, X. Zuo, F. Mao, 2014, Cancer medicine.

Abstract A65: IACS-10759: A novel OXPHOS inhibitor that selectively kills tumors with metabolic vulnerabilities

Edward F. Chang, L. Chin, M. Protopopova, 2016 .

Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity

S. Lippman, J. S. Morris, I. Shureiqi, 2006, Oncogene.